PRKAA1 and atherosclerosis: Enhancement of ECs glycolysis by overexpression of the glucose transporter 1(GLUT1) via adenoviral vectors can attenuate the down-regulation of glycolysis due to AMPKα1 deletion, enhance the activity of ECs, protect endothelial integrity, and finally reverse the susceptibility to the development of atherosclerosis [32].